Axon Enterprise, Inc $AXON Stock Position Decreased by Geneva Capital Management LLC

Geneva Capital Management LLC lowered its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 4.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 87,823 shares of the biotechnology company’s stock after selling 4,176 shares during the period. Geneva Capital Management LLC owned approximately 0.11% of Axon Enterprise worth $37,107,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the company. Ground Swell Capital LLC acquired a new position in shares of Axon Enterprise during the 3rd quarter worth $221,000. Bellwether Advisors LLC purchased a new stake in shares of Axon Enterprise in the 3rd quarter worth about $2,449,000. Wellington Grp LLC boosted its position in shares of Axon Enterprise by 79.4% in the 3rd quarter. Wellington Grp LLC now owns 2,532 shares of the biotechnology company’s stock worth $1,070,000 after buying an additional 1,121 shares in the last quarter. Addison Advisors LLC grew its stake in Axon Enterprise by 160,200.0% in the 3rd quarter. Addison Advisors LLC now owns 1,603 shares of the biotechnology company’s stock valued at $677,000 after acquiring an additional 1,602 shares during the last quarter. Finally, Diversified Trust Co grew its stake in Axon Enterprise by 470.3% in the 3rd quarter. Diversified Trust Co now owns 79,246 shares of the biotechnology company’s stock valued at $33,483,000 after acquiring an additional 65,351 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. The Goldman Sachs Group dropped their target price on shares of Axon Enterprise from $715.00 to $675.00 and set a “buy” rating for the company in a report on Monday, September 21st. Citigroup restated a “market outperform” rating on shares of Axon Enterprise in a research report on Monday, November 2nd. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $390.00 price target on the stock. in a report on Friday, November 6th. JPMorgan Chase & Co. reduced their price target on shares of Axon Enterprise from $755.00 to $610.00 and set an “overweight” rating on the stock in a report on Friday, November 6th. Finally, Raymond James Financial set a $675.00 price target on shares of Axon Enterprise in a research report on Thursday, October 15th. Thirteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average target price of $612.18.

Check Out Our Latest Stock Report on AXON

Insider Buying and Selling

In other Axon Enterprise news, insider Isaiah Fields sold 1,017 shares of the company’s stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $480.45, for a total value of $488,617.65. Following the transaction, the insider directly owned 56,264 shares in the company, valued at approximately $27,032,038.80. This represents a 1.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the company’s stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the transaction, the president owned 296,974 shares in the company, valued at approximately $170,590,774.82. This trade represents a 5.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 37,397 shares of company stock worth $21,234,034. 4.20% of the stock is owned by company insiders.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $315.43 on Monday. Axon Enterprise, Inc has a fifty-two week low of $291.45 and a fifty-two week high of $665.07. The stock has a market cap of $25.69 billion, a price-to-earnings ratio of 101.10, a price-to-earnings-growth ratio of 5.99 and a beta of 1.48. The business has a fifty day moving average of $417.79 and a 200-day moving average of $467.68. The company has a quick ratio of 2.60, a current ratio of 3.00 and a debt-to-equity ratio of 0.76.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.89 by ($0.17). The company had revenue of $908.55 million during the quarter, compared to analysts’ expectations of $934.33 million. Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The firm’s revenue was up 27.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.17 earnings per share. As a group, analysts predict that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

See Also

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.